Richard Christopher - 29 Jul 2025 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: LEXX
Reported as of: 29 Jul 2025
Net transaction value: +$13,641
SEC form: 4
Accepted by SEC: 30 Jul 2025, 11:14:34 UTC
Prior SEC filing: 16 May 2025
Source filing: View source filing
Reporting owner signature: /Richard Christopher/

Key filing fact

Richard Christopher filed Form 4 for Lexaria Bioscience Corp. (LEXX) on 30 Jul 2025.

Key facts

This page summarizes Richard Christopher's Form 4 filing for Lexaria Bioscience Corp. (LEXX).
1 reported transaction and 2 derivative rows are listed below.
Accepted by SEC: 30 Jul 2025, 11:14.

Change

Previous filing in this sequence was filed on 16 May 2025.
Current net transaction value: +$13,641.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001271244 Primary reporting owner

CHRISTOPHER RICHARD

Relationship: Chief Executive Officer, Director
Address: C/O LEXARIA BIOSCIENCE CORP., 100 - 740 MCCURDY ROAD, KELOWNA, BRITISH COLUMBIA, CANADA
Signature: /Richard Christopher/
Signature date: 30 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LEXX transaction

common shares

Purchase

Transaction value: $13,641
Shares: +15,000
Change %: +30%
Price: $0.9094
Shares after: 65,000
Date: 29 Jul 2025
Ownership: Direct

LEXX holding

common shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 50,000
Date: 29 Jul 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 200,000
Date: 29 Jul 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 200,000
Exercise price: $3.92
Footnotes: F1

LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 350,000
Date: 29 Jul 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 150,000
Exercise price: $1.04

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

50,000 options were exercisable on Feb. 28, 2025, an additional 6,818 options are exercisable every month thereafter until November 30, 2026 whereby the balance of 6,822 options will be exercisable December 31, 2026